11/12/2024
9:34 AM | FMR LLC (Filed by)
Prime Medicine (Subject)
| Form SC 13G/A | |
10/24/2024
7:04 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
3:29 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:20 PM | BRISTOL MYERS SQUIBB CO (Filed by)
Prime Medicine (Subject)
| Form SC 13G | |
09/30/2024
6:38 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:26 AM | Prime Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:08 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/07/2024
3:18 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:11 PM | Brudnick Richard (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:11 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
7:05 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:22 AM | Prime Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/04/2024
8:20 PM | Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:01 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:04 AM | Prime Medicine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2024
7:09 AM | Prime Medicine (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
3:21 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2023 GP, L.L.C. (Reporting)
GV 2023 GP, L.P. (Reporting)
GV 2023, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2024
8:35 AM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:01 PM | Alenson Carman (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:03 PM | Duffield Jeremy (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
8:31 PM | ARCH Venture Fund XII, L.P. (Filed by)
Prime Medicine (Subject)
| Form SC 13D | |
02/20/2024
4:37 PM | Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:37 PM | ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Burow Kristina (Reporting)
CRANDELL KEITH (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
GILLIS STEVEN (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:38 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
Prime Medicine (Issuer)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:41 PM | Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:41 PM | NELSEN ROBERT (Reporting)
NELSEN ROBERT (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:23 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
5:17 AM | Prime Medicine (Filer)
| Form 424B5 | |
02/14/2024
8:57 PM | Prime Medicine (Subject)
| Form FWP | |
02/14/2024
4:27 PM | Prime Medicine (Filer)
| Form 424B5 | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Prime Medicine (Subject)
| Form SC 13G/A | |
01/19/2024
3:17 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/19/2024
3:19 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:01 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:03 PM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:15 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
